The Cervical Cancer Vaccine is widely recommended for women because it protects against high-risk strains of the Human Papillomavirus (HPV) that cause cervical cancer. However, it is not limited to women only. Men can also benefit from the vaccine. HPV is a very common infection that can affect both genders, and in men it can cause genital warts, anal cancer, penile cancer, and even some head and neck cancers.
By receiving the Cervical Cancer Vaccine, men reduce their risk of developing HPV-related diseases and also help prevent the spread of the virus to their partners. This provides protection not just for themselves, but also contributes to lowering overall HPV transmission rates in the community.
Health authorities in many countries, including Singapore, recommend the Cervical Cancer Vaccine for both young women and men, ideally before they become sexually active. While it is especially effective when given during adolescence, adults who have not yet been vaccinated may still benefit.
In short, the Cervical Cancer Vaccine is beneficial for both men and women, offering protection against HPV-related cancers and conditions across genders.